Cargando…

Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects

Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. T...

Descripción completa

Detalles Bibliográficos
Autores principales: GUZMÁN-URIBE, Daniela, ALVARADO-ESTRADA, Keila Neri, PIERDANT-PÉREZ, Mauricio, TORRES-ÁLVAREZ, Bertha, SÁNCHEZ-AGUILAR, Jesus Martin, ROSALES-IBÁÑEZ, Raúl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade De Odontologia De Bauru - USP 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393539/
https://www.ncbi.nlm.nih.gov/pubmed/28403359
http://dx.doi.org/10.1590/1678-77572016-0217
_version_ 1783229568157483008
author GUZMÁN-URIBE, Daniela
ALVARADO-ESTRADA, Keila Neri
PIERDANT-PÉREZ, Mauricio
TORRES-ÁLVAREZ, Bertha
SÁNCHEZ-AGUILAR, Jesus Martin
ROSALES-IBÁÑEZ, Raúl
author_facet GUZMÁN-URIBE, Daniela
ALVARADO-ESTRADA, Keila Neri
PIERDANT-PÉREZ, Mauricio
TORRES-ÁLVAREZ, Bertha
SÁNCHEZ-AGUILAR, Jesus Martin
ROSALES-IBÁÑEZ, Raúl
author_sort GUZMÁN-URIBE, Daniela
collection PubMed
description Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissue-engineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. OBJECTIVE: The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral mucosa from diabetic subjects as a first step towards a possible clinical application for cases of diabetic foot. MATERIAL AND METHODS: Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal cells were isolated and cultured using autologous fibrin to develop dermal-epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized with collagen IV and cytokeratin 5-14 as specific markers. A Student´s t- test was performed to assess the differences between both groups. RESULTS: It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression of specific markers were observed and the cytokeratin 5-14 expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, showing a significant difference. CONCLUSION: Cells from oral mucosa could be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues.
format Online
Article
Text
id pubmed-5393539
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Faculdade De Odontologia De Bauru - USP
record_format MEDLINE/PubMed
spelling pubmed-53935392017-04-21 Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects GUZMÁN-URIBE, Daniela ALVARADO-ESTRADA, Keila Neri PIERDANT-PÉREZ, Mauricio TORRES-ÁLVAREZ, Bertha SÁNCHEZ-AGUILAR, Jesus Martin ROSALES-IBÁÑEZ, Raúl J Appl Oral Sci Original Articles Oral mucosa has been highlighted as a suitable source of epidermal cells due to its intrinsic characteristics such as its higher proliferation rate and its obtainability. Diabetic ulcers have a worldwide prevalence that is variable (1%-11%), meanwhile treatment of this has been proven ineffective. Tissue-engineered skin plays an important role in wound care focusing on strategies such autologous dermal-epidermal substitutes. OBJECTIVE: The aim of this study was to obtain autologous dermal-epidermal skin substitutes from oral mucosa from diabetic subjects as a first step towards a possible clinical application for cases of diabetic foot. MATERIAL AND METHODS: Oral mucosa was obtained from diabetic and healthy subjects (n=20 per group). Epidermal cells were isolated and cultured using autologous fibrin to develop dermal-epidermal in vitro substitutes by the air-liquid technique with autologous human serum as a supplement media. Substitutes were immunocharacterized with collagen IV and cytokeratin 5-14 as specific markers. A Student´s t- test was performed to assess the differences between both groups. RESULTS: It was possible to isolate epidermal cells from the oral mucosa of diabetic and healthy subjects and develop autologous dermal-epidermal skin substitutes using autologous serum as a supplement. Differences in the expression of specific markers were observed and the cytokeratin 5-14 expression was lower in the diabetic substitutes, and the collagen IV expression was higher in the diabetic substitutes when compared with the healthy group, showing a significant difference. CONCLUSION: Cells from oral mucosa could be an alternative and less invasive source for skin substitutes and wound healing. A difference in collagen production of diabetic cells suggests diabetic substitutes could improve diabetic wound healing. More research is needed to determine the crosstalk between components of these skin substitutes and damaged tissues. Faculdade De Odontologia De Bauru - USP 2017 /pmc/articles/PMC5393539/ /pubmed/28403359 http://dx.doi.org/10.1590/1678-77572016-0217 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
GUZMÁN-URIBE, Daniela
ALVARADO-ESTRADA, Keila Neri
PIERDANT-PÉREZ, Mauricio
TORRES-ÁLVAREZ, Bertha
SÁNCHEZ-AGUILAR, Jesus Martin
ROSALES-IBÁÑEZ, Raúl
Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title_full Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title_fullStr Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title_full_unstemmed Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title_short Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
title_sort oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393539/
https://www.ncbi.nlm.nih.gov/pubmed/28403359
http://dx.doi.org/10.1590/1678-77572016-0217
work_keys_str_mv AT guzmanuribedaniela oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects
AT alvaradoestradakeilaneri oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects
AT pierdantperezmauricio oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects
AT torresalvarezbertha oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects
AT sanchezaguilarjesusmartin oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects
AT rosalesibanezraul oralmucosaanalternativeepidermiccellsourcetodevelopautologousdermalepidermalsubstitutesfromdiabeticsubjects